NDC product
Moxifloxacin Ophthalmic Solution
NDC 72266-158 · Fosun Pharma USA Inc.
Key facts
| Product NDC | 72266-158 |
|---|---|
| Proprietary name | Moxifloxacin Ophthalmic Solution |
| Nonproprietary name | Moxifloxacin Ophthalmic |
| Substances | MOXIFLOXACIN HYDROCHLORIDE |
| Dosage form | SOLUTION/ DROPS |
| Route | OPHTHALMIC |
| Labeler | Fosun Pharma USA Inc. |
| Product type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Application number | ANDA208778 |
| Pharmacologic classes | Fluoroquinolone Antibacterial [EPC], Fluoroquinolones [CS] |
| Marketing start | Aug 24, 2020 |
| Listing certified through | Dec 31, 2026 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: